[Congressional Record (Bound Edition), Volume 145 (1999), Part 19]
[Senate]
[Page 26806]
[From the U.S. Government Publishing Office, www.gpo.gov]



         PROSTATE CANCER RESEARCH COMMITMENT RESOLUTION OF 1999

  Mr. BROWNBACK. Mr. President, I ask unanimous consent that the 
committee on HELP be discharged from further consideration of S. Res. 
92, and the Senate then proceed to its immediate consideration.
  The PRESIDING OFFICER. Without objection, it is so ordered. The clerk 
will report the resolution by title.
  The legislative assistant read as follows:

       A resolution (S. Res. 92) expressing the sense of the 
     Senate that funding for prostate cancer research should be 
     increased substantially.

  There being no objection, the Senate proceeded to consider the 
resolution.
  Mr. BROWNBACK. I ask unanimous consent that the resolution and 
preamble be agreed to en bloc, the motion to reconsider be laid upon 
the table, and that any statements relating to the resolution be 
printed in the Record, with the above occurring with no intervening 
action.
  The PRESIDING OFFICER. Without objection, it is so ordered.
  The resolution (S. Res. 92) was agreed to.
  The preamble was agreed to.
  The resolution, with its preamble, reads as follows:

                               S. Res. 92

       Whereas in 1999, prostate cancer is expected to kill more 
     than 37,000 men in the United States and be diagnosed in over 
     180,000 new cases;
       Whereas prostate cancer is the most diagnosed nonskin 
     cancer in the United States;
       Whereas African Americans have the highest incidence of 
     prostate cancer in the world;
       Whereas considering the devastating impact of the disease 
     among men and their families, prostate cancer research 
     remains underfunded;
       Whereas more resources devoted to clinical and 
     translational research at the National Institutes of Health 
     will be highly determinative of whether rapid advances can be 
     attained in treatment and ultimately a cure for prostate 
     cancer;
       Whereas the Congressionally Directed Department of Defense 
     Prostate Cancer Research Program is making important strides 
     in innovative prostate cancer research, and this Program 
     presented to Congress in April of 1998 a full investment 
     strategy for prostate cancer research at the Department of 
     Defense; and
       Whereas the Senate expressed itself unanimously in 1998 
     that the Federal commitment to biomedical research should be 
     doubled over the next 5 years: Now, therefore, be it
       Resolved,

     SECTION 1. SHORT TITLE.

       This resolution may be cited as the ``Prostate Cancer 
     Research Commitment Resolution of 1999''.

     SEC. 2. SENSE OF THE SENATE.

       It is the sense of the Senate that--
       (1) finding treatment breakthroughs and a cure for prostate 
     cancer should be made a national health priority;
       (2) significant increases in prostate cancer research 
     funding, commensurate with the impact of the disease, should 
     be made available at the National Institutes of Health and to 
     the Department of Defense Prostate Cancer Research Program; 
     and
       (3) these agencies should prioritize prostate cancer 
     research that is directed toward innovative clinical and 
     translational research projects in order that treatment 
     breakthroughs can be more rapidly offered to patients.

                          ____________________